5 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 http://www.zacks.com/stock/news/730536/jazz-jazz-submits-nda-for-xyrem-follow-on-candidate-jzp-258?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-730536 Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Why Long-Term Investors Should Avoid TEVA Stock Like the Plague https://www.fool.com/investing/2020/01/22/why-long-term-investors-should-avoid-teva-stock-li.aspx?source=iedfolrf0000001 Jan 22, 2020 - Strapped with debt and battling legal controversies right and left, Teva’s best days could very well be behind it.
Why You Should Still Buy Teva https://seekingalpha.com/article/4318277-why-you-should-still-buy-teva?source=feed_tag_israel Jan 22, 2020 - Teva is set to hold the $10 support line.Company's restructuring and debt reduction on schedule.Future growth in place with two products leading it.
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495 Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe http://www.zacks.com/stock/news/727955/jazzs-jazz-new-sleep-drug-sunosi-gets-approval-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-727955 Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.

Pages: 1

Page 1